HK1163660A1 - Benzazepine derivatives useful as vasopressin antagonists - Google Patents

Benzazepine derivatives useful as vasopressin antagonists

Info

Publication number
HK1163660A1
HK1163660A1 HK12103585.1A HK12103585A HK1163660A1 HK 1163660 A1 HK1163660 A1 HK 1163660A1 HK 12103585 A HK12103585 A HK 12103585A HK 1163660 A1 HK1163660 A1 HK 1163660A1
Authority
HK
Hong Kong
Prior art keywords
group
hydroxy
derivatives useful
optionally substituted
vasopressin antagonists
Prior art date
Application number
HK12103585.1A
Other languages
English (en)
Inventor
Kazumi Kondo
Yasuhiro Menjo
Takahiro Tomoyasu
Shin Miyamura
Yuso Tomohira
Takakuni Matsuda
Keigo Yamada
Yusuke Kato
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1163660A1 publication Critical patent/HK1163660A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/5532—Seven-(or more) membered rings
    • C07F9/5535—Seven-(or more) membered rings condensed with carbocyclic rings or ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK12103585.1A 2007-06-26 2010-09-06 Benzazepine derivatives useful as vasopressin antagonists HK1163660A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007167207 2007-06-26

Publications (1)

Publication Number Publication Date
HK1163660A1 true HK1163660A1 (en) 2012-09-14

Family

ID=39773045

Family Applications (3)

Application Number Title Priority Date Filing Date
HK10108445.2A HK1141994A1 (en) 2007-06-26 2010-09-06 Benzazepine derivatives useful as vasopressin antagonists
HK12103585.1A HK1163660A1 (en) 2007-06-26 2010-09-06 Benzazepine derivatives useful as vasopressin antagonists
HK12103584.2A HK1163077A1 (en) 2007-06-26 2010-09-06 Benzazepine derivatives useful as vasopressin antagonists

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK10108445.2A HK1141994A1 (en) 2007-06-26 2010-09-06 Benzazepine derivatives useful as vasopressin antagonists

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK12103584.2A HK1163077A1 (en) 2007-06-26 2010-09-06 Benzazepine derivatives useful as vasopressin antagonists

Country Status (27)

Country Link
US (3) US8669229B2 (zh)
EP (3) EP2374798B1 (zh)
JP (3) JP5653043B2 (zh)
KR (1) KR101487201B1 (zh)
CN (3) CN101687805A (zh)
AR (1) AR067176A1 (zh)
AT (1) ATE545633T1 (zh)
AU (1) AU2008269918B2 (zh)
BR (1) BRPI0813768A2 (zh)
CA (1) CA2690335A1 (zh)
CO (1) CO6160295A2 (zh)
CY (3) CY1113519T1 (zh)
DK (3) DK2374797T3 (zh)
ES (3) ES2380085T3 (zh)
HK (3) HK1141994A1 (zh)
HR (3) HRP20120310T1 (zh)
IL (1) IL202561A0 (zh)
MY (3) MY148312A (zh)
NZ (3) NZ581723A (zh)
PL (3) PL2374797T3 (zh)
PT (3) PT2170831E (zh)
RU (1) RU2471784C2 (zh)
SG (2) SG182230A1 (zh)
SI (3) SI2170831T1 (zh)
TW (1) TWI459947B (zh)
UA (1) UA98966C2 (zh)
WO (1) WO2009001968A1 (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI459947B (zh) * 2007-06-26 2014-11-11 Otsuka Pharma Co Ltd 苯并氮呯化合物及藥學製劑
JP5656399B2 (ja) * 2008-12-26 2015-01-21 大塚製薬株式会社 医薬及び医薬製剤
CN102030709B (zh) * 2009-09-25 2013-10-16 江苏豪森医药集团有限公司 用作加压素受体拮抗剂的苯并氮杂卓类化合物
CN102753530B (zh) 2009-10-26 2015-06-17 大塚制药株式会社 苯并氮杂*化合物
GB201105537D0 (en) 2011-03-31 2011-05-18 Vantia Ltd New process
CN102260213B (zh) * 2011-05-31 2013-05-15 重庆福安药业(集团)股份有限公司 一种托伐普坦的制备方法
TWI633887B (zh) 2012-05-31 2018-09-01 大塚製藥股份有限公司 用於預防及／或治療多囊性腎臟病之藥物
JP6265999B2 (ja) 2012-12-28 2018-01-24 大塚製薬株式会社 光学活性のトルバプタンを含む注射用持効性製剤及びその製造方法
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
TWI660748B (zh) * 2013-03-01 2019-06-01 日商大塚製藥股份有限公司 用於口服投藥之包含非晶型托伐普坦（Ｔｏｌｖａｐｔａｎ）的懸浮液
TW201605488A (zh) 2013-10-15 2016-02-16 大塚製藥股份有限公司 用以預防及／或治療多囊腎病之藥物
US11911369B2 (en) * 2015-03-03 2024-02-27 Biohaven Therapeutics Ltd. Prodrugs of riluzole and their method of use
WO2019003433A1 (ja) * 2017-06-30 2019-01-03 大塚製薬株式会社 ベンゾアゼピン誘導体
CN107540672A (zh) * 2017-10-10 2018-01-05 牡丹江医学院 一种治疗肝硬化的药物及其合成方法
TW201938171A (zh) 2017-12-15 2019-10-01 匈牙利商羅特格登公司 作為血管升壓素Ｖ１ａ受體拮抗劑之三環化合物
HU231206B1 (hu) 2017-12-15 2021-10-28 Richter Gedeon Nyrt. Triazolobenzazepinek
JP2020011957A (ja) * 2019-07-22 2020-01-23 コルセア ファーマ インコーポレイテッド トレプロスチニル誘導体化合物およびその使用方法
CN112851583B (zh) * 2021-01-19 2023-09-08 徐州医科大学 新型苯并氮杂䓬类化合物、组合物及其用途
CA3207957A1 (en) 2021-02-10 2022-08-18 Shanghai Senhui Medicine Co., Ltd. Benzazepine compounds, preparation method therefor and pharmaceutical use thereof
CN113112528A (zh) * 2021-04-26 2021-07-13 中南财经政法大学 异常行为监控方法、装置、设备及存储介质

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5045478A (en) * 1986-03-03 1991-09-03 Becton Dickinson And Company Vesicles and use thereof in an assay
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
TW249201B (zh) * 1992-07-02 1995-06-11 Otsuka Pharma Co Ltd
TW270927B (zh) * 1992-10-16 1996-02-21 Otsuka Pharma Co Ltd
GB9726695D0 (en) * 1997-12-17 1998-02-18 Smithkline Beecham Plc Novel compounds
JP4210355B2 (ja) 1997-07-03 2009-01-14 大塚製薬株式会社 固形製剤組成物
AU763669B2 (en) * 1998-09-29 2003-07-31 Wyeth Holdings Corporation Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
AU2001259701A1 (en) * 2000-05-15 2001-11-26 Paratek Pharmaceuticals, Inc 7-substituted fused ring tetracycline compounds
KR20070085544A (ko) 2004-11-02 2007-08-27 뉴 리버 파마슈티칼스 인크. 간 전달이 개선된 리바비린의 프로드러그
PL1968990T3 (pl) * 2005-12-27 2015-06-30 Otsuka Pharma Co Ltd Rozpuszczalny w wodzie związek benzoazepinowy i jego kompozycja farmaceutyczna
TWI459947B (zh) * 2007-06-26 2014-11-11 Otsuka Pharma Co Ltd 苯并氮呯化合物及藥學製劑

Also Published As

Publication number Publication date
SI2374798T1 (sl) 2013-10-30
HRP20120310T1 (hr) 2012-06-30
US20140024619A1 (en) 2014-01-23
EP2374798A1 (en) 2011-10-12
NZ598064A (en) 2013-04-26
JP5893085B2 (ja) 2016-03-23
EP2170831B1 (en) 2012-02-15
CN101687805A (zh) 2010-03-31
US20110071084A1 (en) 2011-03-24
US8669229B2 (en) 2014-03-11
IL202561A0 (en) 2010-06-30
RU2471784C2 (ru) 2013-01-10
DK2374797T3 (da) 2014-05-12
AR067176A1 (es) 2009-09-30
RU2010102229A (ru) 2011-08-10
AU2008269918B2 (en) 2012-12-06
AU2008269918A1 (en) 2008-12-31
JP5653043B2 (ja) 2015-01-14
UA98966C2 (ru) 2012-07-10
CO6160295A2 (es) 2010-05-20
ES2380085T3 (es) 2012-05-08
ES2460018T3 (es) 2014-05-13
KR20100040873A (ko) 2010-04-21
EP2374797B1 (en) 2014-03-26
PL2374798T3 (pl) 2014-01-31
NZ598067A (en) 2012-12-21
HK1163077A1 (en) 2012-09-07
DK2374798T3 (da) 2013-10-07
EP2374798B1 (en) 2013-09-04
KR101487201B1 (ko) 2015-01-28
WO2009001968A1 (en) 2008-12-31
CN103342679A (zh) 2013-10-09
ATE545633T1 (de) 2012-03-15
NZ581723A (en) 2012-03-30
SI2374797T1 (sl) 2014-05-30
US9073868B2 (en) 2015-07-07
SI2170831T1 (sl) 2012-04-30
CY1113519T1 (el) 2016-06-22
CY1115226T1 (el) 2017-01-04
HRP20140501T1 (hr) 2014-07-04
PT2374798E (pt) 2013-11-05
ES2431515T3 (es) 2013-11-26
PT2170831E (pt) 2012-04-13
SG182231A1 (en) 2012-07-30
PL2374797T3 (pl) 2014-08-29
CY1114491T1 (el) 2016-10-05
US20140024640A1 (en) 2014-01-23
MY152805A (en) 2014-11-28
MY150941A (en) 2014-03-14
SG182230A1 (en) 2012-07-30
JP2010531293A (ja) 2010-09-24
HRP20131095T1 (hr) 2014-01-03
JP2014208680A (ja) 2014-11-06
JP5689195B2 (ja) 2015-03-25
EP2170831A1 (en) 2010-04-07
BRPI0813768A2 (pt) 2014-12-30
CA2690335A1 (en) 2008-12-31
PT2374797E (pt) 2014-05-02
EP2374797A1 (en) 2011-10-12
US8785386B2 (en) 2014-07-22
JP2014205703A (ja) 2014-10-30
CN103342680A (zh) 2013-10-09
DK2170831T3 (da) 2012-05-21
TW200911271A (en) 2009-03-16
TWI459947B (zh) 2014-11-11
PL2170831T3 (pl) 2012-08-31
MY148312A (en) 2013-03-29
HK1141994A1 (en) 2010-11-26

Similar Documents

Publication Publication Date Title
HK1163660A1 (en) Benzazepine derivatives useful as vasopressin antagonists
TW200626610A (en) Analogs of 17-hydroxywortmannin as PI3K inhibitors
MX2009005449A (es) Compuesto heteromonociclico y uso del mismo.
MX2009005461A (es) N-oxidos de analogos de 4,5-epoxi-morfinano.
MX2009010024A (es) Nuevo compuesto de adenina.
MX342683B (es) Analogos de ciclopamina.
TW200637559A (en) 3-propenylcefem derivative
HK1119699A1 (en) Pyridopyrimidinone inhibitors of pi3kalpha
IL190971A0 (en) Method and compounds for preparing cc-1065 analogs
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
MX2009008781A (es) Derivados de ciclohexano espirociclicos.
WO2007084914A3 (en) Phenoxy-substituted pyrimidines as adenosine receptor antagonists
JO2741B1 (en) Spiro-cyclic nitroblast as protease inhibitors
EA201171387A1 (ru) Производные 7-азаспиро[3,5]нонан-7-карбоксилатов, их получение и их применение в терапии
MX2011007952A (es) Tricianoboratos novedosos.
MY143581A (en) Carboxamide derivatives as muscarinic receptor antagonists
WO2007033039A3 (en) Proteasome inhibiting beta lactam compounds
SI1891952T1 (sl) Farmacevtski sestavek, ki vsebuje olmesartan medoksomil
GB2452436A (en) Substituted N-Acyl homoserine lactones
PE20060103A1 (es) Nuevas 5-acilindolinonas con contenido en cicloalquilo y su preparacion como medicamento
BR112012009861A2 (pt) composto, composição farmacêutica, e, uso do composto.
MX2011007272A (es) Piperidinas de aroilamino y heteroaroilamino sustituidas como inhibidores de glyt-1.
EP1825856A4 (en) ORAL COMPOSITION CONTAINING DIFRUCTOSE ANHYDRIDE
HK1130496A1 (en) 3'-ethynylcytidine derivative 3'-
WO2008117861A1 (ja) フェニレンジアミン誘導体を有効成分とする眼圧下降剤

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170626